FDA approves Memo 3D ReChord for Mitral Valve Disease-Sorin
Sorin Group has announced FDA clearance for Memo 3D ReChord, an innovative semi-rigid annuloplasty ring for repair in patients with Mitral Valve Disease. Memo 3D ReChord incorporates an innovative chordal guide system into the existing Memo 3D ring to simplify and standardize the approach to artificial chord replacement.
Its design streamlines mitral repair procedures while allowing surgeons to obtain reproducible results even in advanced chordal reconstructions. Other features include a temporary chordal guide system that simplifies artificial chord replacement, Carbofilm coating to enhance hemo-compatibility and an innovative cell-structure design to accommodate the mitral saddle shape while enabling the physiological 3D motion of the native annulus.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins